Konstantin Matentzoglu is currently a Partner at CDL Therapeutics GmbH and at PREDICTION BIOSCIENCES, while also holding various supervisory board positions at Rezon Bio, JJP Biologics, BSP Pharmaceuticals S.p.A., and Polpharma Biologics. Previously, they served as a Partner at Trenzyme GmbH from 2009 to 2020 and as SVP of Business Development at AyoxxA Biosystems from 2012 to 2014. With a wealth of experience in the biopharmaceutical sector, Konstantin continues to contribute to the growth of innovative companies in Europe.
This person is not in the org chart
This person is not in any teams
This person is not in any offices